Trial · NCT06955923
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Pain Scores on the Visual Analog Scale | Experimental Group - Participants Receiving Trigger Point Injections | Change from Baseline to Post Operative Day (POD) 1 | 51 | Standard Deviation 29.51 | Pain Scores on the Visual Analog Scale |
| Pain Scores on the Visual Analog Scale | Sham Comparator - Participants Not Receiving Trigger Point Injections | Change from Baseline to Post Operative Day (POD) 1 | 55 | Standard Deviation 22.64 | Pain Scores on the Visual Analog Scale |
| Pain Scores on the Visual Analog Scale | Experimental Group - Participants Receiving Trigger Point Injections | Change from POD1 to week 2 follow-up | 40 | Standard Deviation 14.49 | Pain Scores on the Visual Analog Scale |
| Pain Scores on the Visual Analog Scale | Sham Comparator - Participants Not Receiving Trigger Point Injections | Change from POD1 to week 2 follow-up | 42 | Standard Deviation 24.9 | Pain Scores on the Visual Analog Scale |
| Pain Scores on the Visual Analog Scale | Experimental Group - Participants Receiving Trigger Point Injections | Change from week 2 to week 6 follow-up | 30 | Standard Deviation 32.79 | Pain Scores on the Visual Analog Scale |
| Pain Scores on the Visual Analog Scale | Sham Comparator - Participants Not Receiving Trigger Point Injections | Change from week 2 to week 6 follow-up | 28.33 | Standard Deviation 18.93 | Pain Scores on the Visual Analog Scale |
| Opioid Use | Experimental Group - Participants Receiving Trigger Point Injections | POD1 | 50.08 | Standard Deviation 36.89 | MME |
| Opioid Use | Sham Comparator - Participants Not Receiving Trigger Point Injections | POD1 | 68.60 | Standard Deviation 33.8 | MME |
| Opioid Use | Experimental Group - Participants Receiving Trigger Point Injections | week 2 | 23.09 | Standard Deviation 12.21 | MME |
| Opioid Use | Sham Comparator - Participants Not Receiving Trigger Point Injections | week 2 | 19.09 | Standard Deviation 16.69 | MME |
| Opioid Use | Experimental Group - Participants Receiving Trigger Point Injections | week 6 | 1.33 | Standard Deviation 2.1 | MME |
| Opioid Use | Sham Comparator - Participants Not Receiving Trigger Point Injections | week 6 | 0 | Standard Deviation 0 | MME |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06955923/results